Cureteq is an asset management and biotechnology company - enabled by artificial intelligence (AI). The cureteq platform has three main components: First, leveraging AI and data insights to in license drug candidates from pharmaceutical companies and biotech to unlock hidden value, e.g. assets that have gone under-prioritized or with promising data but outside company strategy. Further utilize AI in devising accelerated, optimized and de-risked clinical development programs. Second, an ecosystem of connected, yet independent, subsidiaries with each their disease area focus and leading the drug development of acquired assets; this secures agile and nimble drug development while retaining economies of scale and broader access to competences and resources as known from larger organizations. Finally, and third, flexibility around financing and partnering for each asset and subsidiary - patterning can be tailored to match the specific needs of asset, partners and investors.